![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Scope Fluidics’ COVID-19 Test Gets CE Mark
Scope Fluidics’ COVID-19 Test Gets CE Mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
Scope Fluidics has received the CE mark for its PCR ONE polymerase chain reaction test for COVID-19.
The test has a 91.2 percent sensitivity in identifying those infected with the disease and 100 percent specificity in correctly identifying people without the disease, Scope Fluidics said.
Because it is designed to test for a number of targets in the SARS-CoV-2 genome, it can be adapted to pick up new variants of the virus, the company said.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct